UY30556A1 - DERIVATIVES 2, 7-SUBSTITUTES OF 4- (3-METHYLMORFOLIN-4-IL) PIRIDO [2,3-D] PYRIMIDINES AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS - Google Patents
DERIVATIVES 2, 7-SUBSTITUTES OF 4- (3-METHYLMORFOLIN-4-IL) PIRIDO [2,3-D] PYRIMIDINES AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONSInfo
- Publication number
- UY30556A1 UY30556A1 UY30556A UY30556A UY30556A1 UY 30556 A1 UY30556 A1 UY 30556A1 UY 30556 A UY30556 A UY 30556A UY 30556 A UY30556 A UY 30556A UY 30556 A1 UY30556 A1 UY 30556A1
- Authority
- UY
- Uruguay
- Prior art keywords
- pharmaceutically acceptable
- methylmorfolin
- pirido
- pyrimidines
- substitutes
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003230 pyrimidines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se proporciona un compuesto un compuesto de formula I: o una sal farmacéuticamente aceptable del mismo. También se proporcionan procesos para la fabricacion de un compuesto de Formula I, y el uso de un compuesto de Formula I como medicamento para tratamiento del cáncer.A compound is provided a compound of formula I: or a pharmaceutically acceptable salt thereof. Processes are also provided for the manufacture of a Formula I compound, and the use of a Formula I compound as a medicament for cancer treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY30556A UY30556A1 (en) | 2007-08-22 | 2007-08-22 | DERIVATIVES 2, 7-SUBSTITUTES OF 4- (3-METHYLMORFOLIN-4-IL) PIRIDO [2,3-D] PYRIMIDINES AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY30556A UY30556A1 (en) | 2007-08-22 | 2007-08-22 | DERIVATIVES 2, 7-SUBSTITUTES OF 4- (3-METHYLMORFOLIN-4-IL) PIRIDO [2,3-D] PYRIMIDINES AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY30556A1 true UY30556A1 (en) | 2008-03-31 |
Family
ID=39247294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY30556A UY30556A1 (en) | 2007-08-22 | 2007-08-22 | DERIVATIVES 2, 7-SUBSTITUTES OF 4- (3-METHYLMORFOLIN-4-IL) PIRIDO [2,3-D] PYRIMIDINES AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS |
Country Status (1)
| Country | Link |
|---|---|
| UY (1) | UY30556A1 (en) |
-
2007
- 2007-08-22 UY UY30556A patent/UY30556A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY30819A1 (en) | DERIVATIVES OF PIRAZOL, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS | |
| ECSP109935A (en) | PYRIMIDINE MORFOLINE DERIVATIVES USED IN DISEASES RELATED TO MTOR QUINASA AND / OR PI3K | |
| NI201000003A (en) | TRISUSTITUED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES. | |
| NI201000004A (en) | TRISUSTITUED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES. | |
| UY32462A (en) | NEW BIFENYLL DERIVATIVES FOR HEPATITIS C 644 VIRUS INFECTION TREATMENT | |
| CR20150628A (en) | DERIVATIVES OF PIRAZOLOPIRROLIDINE AND ITS USE IN THE TREATMENT OF DISEASES | |
| SV2011004077A (en) | AMINOBUTIRIC DERIVATIVES REPLACED AS NEPRILISINE INHIBITORS | |
| UY30559A1 (en) | DERIVATIVES OF MORFOLINO PIRIMIDINA, PREPARATION PROCESSES, COMPOSITIONS CONTAINING THEM AND APPLICATIONS | |
| CO6480932A2 (en) | ANTAGONISTS OF THE HEDGEHOG TRAJECTORY OF DISTTITUTED FTALAZINA. | |
| ECSP10010419A (en) | UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME-211 | |
| UY32158A (en) | HETEROCICLIC DERIVATIVES AND METHODS OF USE OF THE SAME | |
| UY31254A1 (en) | SUBSTITUTED DERIVATIVES OF N4- (5-METHYL-1H-PIRAZOL-3-IL) - 1,3,5-TRIAZINA-2,4-DIAMINE, THEIR ENANTIOMERS, PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, COMPOSITIONS, PREPARATION PROCESSES AND APPLICATIONS | |
| EA201100971A1 (en) | DERIVATIVES OF PYRIMIDININDOL FOR THE TREATMENT OF MALIGNANT NORMALIZATION | |
| ECSP088973A (en) | IMIDAZOL PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE SYNTHETIC KINASE GLYCOGEN (GSK3) | |
| UY30282A1 (en) | CHEMICAL COMPOUNDS | |
| UY30316A1 (en) | SUBSTITUTED DERIVATIVES OF BENZAMIDS, NICOTINAMIDS, PROPANAMIDS, ACETAMIDS AND CARBOXAMIDS N- (2- (PIPERIDIN-1-ILMETIL) CICLOHEXIL) REPLACED, PREPARATION PROCESSES, COMPOSITIONS CONTAINING AND APPLICATIONS | |
| CY1114140T1 (en) | 4-PYRIDINONE COMPONENTS AND THEIR USE FOR CANCER | |
| NI200900183A (en) | PYRID [2,3-D] PYRIMIDINE - 7 - ONA COMPOUNDS AS PI3K - ALPHA INHIBITORS FOR THE TREATMENT OF CANCER. | |
| UY32055A (en) | Substituted derivatives of 5-Halo-N2- [substituted] (1-methyl-1H-imidazol-4-yl) pyrimidin-2, -diamine and its pharmaceutically acceptable salts, preparation processes, compositions and applications. | |
| UY31141A1 (en) | PIPERIDINE COMPOUNDS AND ITS USES | |
| CR11825A (en) | UREA HETEROCICLIC DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS | |
| UY32674A (en) | UREA HETEROCICLICAL DERIVATIVES AND THEIR EMPLOYMENT METHODS | |
| PE20151607A1 (en) | ORGANIC COMPOUND FORMULATIONS | |
| UY31865A (en) | HETEROCYCLIC UREA DERIVATIVES AND METHODS FOR THE USE OF THE SAME | |
| CO6321280A2 (en) | NEW ESPIRO PIPERIDINAS CLASS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20170725 |